 |
 |
|
||||||||
|
|
|
|
|
|
|
||
|
|
|
||||||
 |
|
A Comprehensive Approach: Chapter 3, Section 5: References Academy for Educational Development (AED). Comprehensive HIV prevention services for injection drug users: an assessment of state and local technical assistance issues and priorities. Washington (DC): AED; August 1999. Prepared for the Centers for Disease Control and Prevention. Ary DV, Duncan TE, Biglan A, Metzler CW, Noell JW, Smolkowski K. Development of adolescent problem behavior. Journal of Abnormal Child Psychology 1999;27(2):141-150. Belenko S. Behind bars: substance abuse and
America's prison population. New York: National Center on Addiction
and Substance Abuse at Columbia University (CASA); January, 1998. www.casacolumbia.org Berger JM, Levin SM. Adolescent substance abuse and HIV/AIDS: linking the systems. Journal of Adolescent Chemical Dependency 1993;2(3/4):49-56. Booth RE, Kwiatkowski CF, Weissman G. Health-related service utilization and HIV risk behaviors among HIV infected drug users and crack smokers. Drug and Alcohol Dependence 1999;55(102):69-78. Botvin GJ, Baker E, Dusenbury L, Botvin EM, Diaz T. Longterm followup results of a randomized drug abuse prevention trial in a white middle-class population. JAMA 1995a;273(14):1106-1112. Botvin GJ, Baker E, Filazzola AD, Botvin EM. A cognitive-behavioral approach to substance abuse prevention: one-year follow-up. Addictive Behaviors 1990;15(1):47-63. Botvin GJ, Schinke SP, Epstein JA, Diaz T, et al. Effectiveness of culturally focused and generic skills training approaches to alcohol and drug abuse prevention among minority adolescents: two-year followup results. Psychology of Addictive Behaviors 1995b;9(3):183-194. Bry BH, Catalano RF, Kumpfer KL, Lochman JE, Szapocznik
J. Scientific
findings from family prevention intervention research. Calsyn DA, Meinecke C, Saxon AJ, Stanton V. Risk reduction in sexual behavior: a condom give away program in a drug abuse treatment clinic. American Journal of Public Health 1992;82(11):1536-1538. Calzavara L, et al. Understanding HIV-related risk behavior in prison: the inmates perspective. Toronto: University of Toronto, Faculty of Medicine, HIV Social, Behavioral and Epidemiological Studies Unit; 1997. Centers for Disease Control and Prevention/AIDS Community Demonstration Projects Research Group (CDC/ACDP). Community-level HIV intervention in five cities: final outcome data from CDC AIDS Community Demonstration Projects. American Journal of Public Health 1999;89(3):336-345. Centers for Disease Control and Prevention (CDC). Hepatitis B fact sheet. June 1999. Centers for Disease Control and Prevention (CDC). Dangerous intersection of drug use and sexual HIV transmission points to critical need for comprehensive HIV prevention among drug users. 1998a. www.cdc.gov/hiv/pubs/facts/idu.htm Centers for Disease Control and Prevention (CDC). Update: HIV counseling and testing using rapid tests - United States, 1995. Morbidity and Mortality Weekly Report 1998b Mar 27;47(11):211-215. Centers for Disease Control and Prevention (CDC). Continued sexual risk behavior among HIV-seropositive drug-using men-Atlanta; Washington, DC; San Juan, Puerto Rico, 1993. Morbidity and Mortality Weekly Report 1996;45:151-152. Centers for Disease Control and Prevention (CDC). Counseling and testing intravenous-drug users for HIV infection-Boston. Morbidity and Mortality Weekly Report 1989 Jul 21;38(28):489-90, 495-496. Chu A, Torbert A, Brown A, Ellison J, Matthew I, McFarland J, Forlenza S. Overlapping AIDS epidemic among injecting drug use (IDU) and heterosexual exposure (HT) in New York City (NYC) AIDS cases. 1998; 5th Conference on Retrovirology and Opportunistic Infections, February 1-5. P.103 (Abstract No. 129). Cohen A, Kibel B, Stewart K. Corby NH, Rhodes F, Wolitski RJ. Substance use
and sexual behavior among gay/bisexual men at an alternative test site.
IV International Conference on AIDS, Stockholm, Sweden; 1988.
Des Jarlais DC, Hagan H, Friedman SR, Friedmann
P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A,
et al. Maintaining low HIV seroprevalence in populations of injection
drug users. JAMA 1995; 274:1226-1231.
Dishion T J, Kavanagh K, Kiesner J. Prevention
of early adolescent substance abuse among high-risk youth: a multiple
gating approach to parent intervention. Dolan KA, et al. A network of HIV infection among
Australian inmates. Poster abstract no. We.D.3655, presented at the
11th International Conference on AIDS, Vancouver, July 10, 1996.
Donaldson SI, Graham JW, Hansen WB. Testing the
generalizability of intervening mechanism theories: understanding the
effects of adolescent drug use prevention interventions. Journal
of Behavioral Medicine 1994;17(2):195-216.
Donovan JE, Jessor R, Costa FM. Syndrome of problem
behavior in adolescence: a replication. Journal of Consulting and
Clinical Psychology 1988;56(5):762-765.
Drug Strategies. Making
the grade: a guide to school drug prevention programs. Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C,
Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD. Intersecting
epidemics: crack cocaine use and HIV infection among inner-city adults.
New England Journal of Medicine 1994;331(21):1422-1427.
Eggert LL, Thompson EA, Herting JR Nicholas LJ.
Reducing suicide potential among high-risk youth: tests of a school-based
prevention program. Suicide and Life-Threatening Behavior 1995;25(2):276-296.
Eggert LL, Thompson EA, Herting JR, Nicholas LJ,
Dicker BG. Preventing adolescent drug abuse and high school dropout
through an intensive school-based social network development program.
American Journal of Health Promotion 1994;8(3):202-215.
El-Bassel N, Schilling RF. 15-month follow-up
of women methadone patients taught skills to reduce heterosexual HIV
transmission. Public Health Reports 1992;107(5):500-504.
Epstein J, Gfroerer J. Changes
affecting NHSDA estimates of treatment need for 1994-1996. Farrell AD, Danish SJ, Howard CW. Relationship
between drug use and other problem behaviors in urban adolescents. Journal
of Consulting and Clinical Psychology 1992;60:705-712.
Friedman SR, Curtis R, Neaigus A, Jose B, Des
Jarlais DC. Social networks, drug injectors's lives, and HIV/AIDS. New
York: Kluwer/Plenum Press; 1999.
Friedman SR, Des Jarlais DC, Ward TP. Social models
for changing health-relevant behavior. In: DiClemente R, Peterson J,
editors. Preventing AIDS: theories and methods of behavioral interventions.
New York: Plenum Press; 1994; pp. 95-116.
Friedman SR, Des Jarlais DC, Ward TP, Jose B,
Neaigus A, Goldstein M. Drug injectors and hetero sexual AIDS. In: Sherr
L, editor. AIDS and the heterosexual population, Chur (Switzerland):
Harwood Academic Publishers; 1993; pp.41-65.
Gerstein DR, Harwood HJ, editors. Treating drug
problems. Vol. I: A study of the evolution, effectiveness, and financing
of public and private drug treatment systems. Washington (DC): National
Academy Press; 1990.
Goldberg L, Elliot D, Clarke GN, MacKinnon DP,
Moe E, Zoref L, Green C, Wold SL, Greffrath E, Miller DJ, Lapin A. Effects
of a multidimensional anabolic steroid prevention intervention: the
ATLAS (Adolescents Training and Learning to Avoid Steroids) program.
JAMA 1996a;276:1555-1562.
Goldberg L, Elliot DL, Clarke GN, MacKinnon DP,
Zoref L, Moe E, Green C, Wolf S. The Adolescents Training and Learning
to Avoid Steroids (ATLAS) prevention program: background and results
of a model intervention. Archives of Pediatric and Adolescent Medicine
1996 b;150:713-721.
Gostin LO. The legal environment impeding access
to sterile syringes and needles: the conflict between law enforcement
and public health. Journal of Acquired Immune Deficiency Syndromes
and Human Retrovirology 1998;18(Suppl 1):S60-S70.
Groseclose SL, Weinstein B, Jones T S, Valleroy
LA, Fehrs LJ, Kassler W J. Impact of increased legal access to needles
and syringes on the practices of injecting-drug users and police officers-Connecticut,
1992-93. Journal of Acquired Immune Deficiency Syndromes and Human
Retrovirology 1995;10:82-89.
Hammett TM, Harmon P, Maruschak LM. 1996-1997
Update: HIV/AIDS, STDs, and TB in correctional facilities. Issues
and Practices in Criminal Justice Hawkins JD, Catalano RF, Miller JY. Risk and protective
factors for alcohol and other drug problems in adolescence and early
adulthood: implications for substance abuse prevention. Psychological
Bulletin 1992;112(1):64-105.
Health Resources and Services Administration (HRSA).
Evaluation of the effects of Ryan White Title I funding on services
for HIV-infected drug abusers, baseline data. Year 1: summary report.
Rockville (MD): HRSA; August, 1994. www.hab.hrsa.gov/publications.html Hubbard RL, Marsden ME, Rachal JV, Harwood HJ,
Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study
of effectiveness. Chapel Hill (NC): University of North Carolina
Press; 1989.
Keenan JM. Summary of research agenda. In: Conference
proceedings of the Agency for Health Care Policy and Research (AHCPR)
community based care of persons with AIDS: developing a-research agenda.Rockville
(MD): U.S. Department of Health and Human Services, Public Health Service;
1990; pp.169-172.
Kumpfer KL, Molraard V, Spoth R. The "Strengthening
Families Program" for the prevention of delinquency and drug use. In:
Peters R, McMahon R, editors. Preventing childhood disorders, substance
abuse, and delinquency. Thousand Oaks (CA): Sage Publications; 1996.
Kwiatkowski CF, Booth RE. HIV-seropositive drug
users and unprotected sex. AIDS and Behavior 1998;2(2):151-159.
Lauby JL, Smith PJ, Start M, Person B, Adams J.
A community-level HIV prevention intervention for inner-city women:
results of the Women and Infants Demonstration Projects. American
Journal of Public Health 2000;90(2):216-222.
Levy JA, Fox SE. The outreach-model of partner
notification with IDUs. Public Health Reports 1998;113(Suppl
1):160-169.
Lurie P, Jones TS, Foley J. A sterile syringe
for every drug user injection: how many injections take place annually,
and how might pharmacists contribute to syringe distribution? Journal
of Acquired Immune Deficiency Syndromes and Human Retrovirology
1998;18(Suppl 1):S45-S51.
Malow RM, West JA, Corrigan SA, Pena JM, Cunningham
SC. Outcome of psychoeducation for HIV risk reduction. AIDS Education
and Prevention 1994;6(2):113-125.
Mahon N. New York inmates' HIV risk behaviors:
the implications for prevention policy and programs. American Journal
of Public Health 1996;86:1211-1215.
McCusker J, Stoddard AM, Zapka JG, Zorn M. Use
of condoms by heterosexually active drug abusers before and after AIDS
education. Sexually Transmitted Diseases 1993;20(2):81-88.
Metsch L, McCoy C, Lai S, Miles C. Continuing
risk behaviors among HIV-seropositive chronic drug users in Miami, Florida.
AIDS and Behavior 1998;2(2):161-169.
Metzger DS, Navaline H, Woody GE. Drug abuse treatment
as AIDS prevention. Public Health Reports 1998;113(Suppl1):97-106.
National Alliance of State and Territorial AIDS
Directors (NASTAD). HIV
prevention and access to sterile syringes. National Institutes of Health (NIH). Effective
medical treatment of opiate addiction. National Institutes of Health (NIH). Interventions
to prevent HIV risk behaviors. National Institute on Drug Abuse (NIDA). Principles
of drug addiction treatment: a research-based guide. National Institute on Drug Abuse (NIDA). Preventing
drug use among children and adolescents: a research-based guide. New York Harm Reduction Educators, Inc. (NYHRE).
Harm reduction training part 1: drug users, drug using behavior and
service delivery. A report produced for the New York State AIDS
Institute, November, 1998.
O'Brien CP, McLellan AT. Myths about the treatment
of addiction. Lancet 1996;347:237-240.
Osgood DW, Johnston LS, O'Malley PM, Bachman JG.
The generality of deviance in late adolescence and early adulthood.
American Sociological Review 1988;53:81-93.
Pentz MA. The school-community interface in comprehensive
school health education. In: Stansfield S, editor. 1996 Institute
of Medicine Annual Report, Committee on Comprehensive School Health
Programs.Institute of Medicine. Washington (DC): National Academy
Press; 1995.
Pentz MA, Dwyer JH, MacKinnon DP, Glay BR, Hansen
WB, Wang EY, Johnson CA. A multi-community trial for primary prevention
of adolescent drug abuse: effects on drug use prevalence. JAMA
1989;261:3259-3266.
Pickens RW, Leuke feld CG, Schuster CR, editors.
NIDA Research Monograph 106: improving drug abuse treatment.
Rockville (MD): National Institute on Drug Abuse; 1991 DHHS Publication
No. (ADM) 91-1754; NTIS PB#92-105873.
Remis RS, Bruneau J, Hankins CA. Enough sterile
syringes to prevent HIV transmission among injection drug users in Montreal?
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
1998;18(Suppl 1):S57-S59.
Rogers SJ, Tross S, Doino-Ingersol J, Weisfuse
I. Partner notification with HIV- infected drug users: results of formative
research. AIDS Care 1998;10(4):415-429.
Rusche S. Voluntary organizations. In: Coombs RH,
Ziedonis DM, editors. Handbook on drug abuse prevention: a comprehensive
strategy to prevent the abuse of alcohol and other drugs. Boston
(MA): Allyn and Bacon; 1995. p. 181-195.
Spoth R. Family-focused
prevention intervention research: a pragmatic perspective on issues
and future directions. Strain EC, Bigelow GE, Liebson IA, Stitzer ML.
Moderate-
vs. high-dose methadone in the treatment of opioid dependence: a randomized
trial. Struckman-Johnson C, Struckman-Johnson D, Rucker
L, Bumby K, Donaldson S. Sexual coercion reported by men and women in
prison. Journal of Sex Research 1996;33:67-76.
Thaca I. One junkie's odyssey: drug users and the health care system. Thiede H, Hagan H, Murrill CS. Methadone treatment
and HIV and hepatitis B and C risk reduction among injectors in the
Seattle area. Journal of Urban Health 2000;77(3):331-345.
Valleroy LA, Weinstein B, Jones TS, Groseclose
SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles
and syringes on community pharmacies needle and syringe sales-Connecticut,
1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human
Retrovirology 1995;10(1):73-81.
Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann
P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman
SR. Condom use with primary partners among injecting drug users in Bangkok,
Thailand and New York City, USA. AIDS 1993;7(6):887-891.
Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic
B, Lampinen T, Murray J, O'Brien MU. Risk behavior and HIV seroincidence
among out-of-treatment injection drug users: a four-year prospective
study. Journal of Acquired Immune Deficiency Syndromes and Human
Retrovirology. 1996;12(3):282-289. This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content. |
|||||||||||||||||||||||
|
|
|
|
|
Privacy Policy | Accessibility
|
|
|
|
